Tissue Tolerance of Diclofenac Sodium Encapsulated in Liposomes After Intramuscular Administration
- 1 January 2002
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 28 (6) , 673-680
Abstract
In this work the effect of the encapsulation of diclofenac sodium within liposomes on the reduction of the myotoxicity after intramuscular administration in rats was studied. Diclofenac sodium was encapsulated in small unilamellar liposomes obtained from phosphatidylcholine, cholesterol, and α-tocopherol (40:10:0.04 mM), and administered by intramuscular injection in the quadriceps femoral muscle of male Wistar rats. After a single dose of 0.2 mg diclofenac formulations the local tissue damage was assessed by plasma creatine kinase (CPK) activity and histological analysis. It was demonstrated that formulations containing free diclofenac produced a higher increase in CPK activity, while those encapsulated in liposomes exhibited CPK activity similar to the control groups. Histopathological analysis of local muscle tissue performed on the third and seventh days following the injection showed intense cellular damage when free drug solution was used, while encapsulation in liposome protected the tissue against the local tissue inflammation.Keywords
This publication has 24 references indexed in Scilit:
- Passive Targeting of Doxorubicin with Polymer Coated Liposomes in Tumor Bearing Rats.Biological and Pharmaceutical Bulletin, 2001
- Piroxicam Encapsulated in Liposomes: Characterization and In Vivo Evaluation of Topical Anti-inflammatory EffectDrug Development and Industrial Pharmacy, 1999
- Other applications1998
- Mechanism for Enhancement Effect of Lipid Disperse System on Percutaneous AbsorptionJournal of Pharmaceutical Sciences, 1996
- Effect of Formulation Variables on Dissolution Profile of Diclofenac Sodium from Ethyl- and Hydroxypropylmethyl Cellulose TabletsDrug Development and Industrial Pharmacy, 1996
- Rabbit model for estimating relative bioavailability, residues and tissue tolerance of intramuscular products: comparison of two ampicillin productsJournal of Veterinary Pharmacology and Therapeutics, 1995
- Liposomes as carriers for anti-inflammatory agentsAdvanced Drug Delivery Reviews, 1989
- ADVERSE REACTIONS AFTER INTRAMUSCULAR INJECTIONSThe Lancet, 1983
- The rate of elimination and distribution volume of rabbit muscle creatine phosphokinase.Chemical and Pharmaceutical Bulletin, 1983
- Toxicity of free and liposome-encapsulated adriamycin following large volume, short-term intraperitoneal exposure in the ratToxicology and Applied Pharmacology, 1982